Muhsin ÖZDEMİR, Faruk SAYDAM, Emel KURT, İrfan DEĞİRMENCİ

Is there a genetic predisposition for Turkish patients with sarcoidosis in the 329-bp region containing the BTNL2 rs2076530 polymorphism?

Sarcoidosis is a complex, multifactorial immune disorder with unknown etiology. A single nucleotide polymorphism ( G->A, rs2076530) in the butyrophilin-like 2 (BTNL2) gene results in a truncating protein formation. It has been previously reported that this variation may be a risk factor for sarcoidosis in certain ethnic groups. This study was conducted to determine whether there is any genetic predisposition for the BTNL2 rs2076530 polymorphism in the 329-bp region in Turkish patients with sarcoidosis. Materials and methods: DNA samples were obtained from volunteers including 53 Turkish patients with sarcoidosis and 52 healthy controls. Analysis of the 329-bp region was carried out by polymerase chain reaction and sequencing of genomic DNA. Results: We did not find any genetic variation except the rs2076530 polymorphism in the 329-bp region. The AA genotype was associated with an increased risk of sarcoidosis in a recessive model [P = 0.027, OR 2.56 (95% CI 1.02-6.49)], but it did not include a risk for sarcoidosis in a dominant model (P = 0.885). Conclusion: Our results emphasize the recessive characteristic of the rs2076530 polymorphism in Turkish patients with sarcoidosis. The lack of any genetic variation except rs2076530 in the 329-bp region is another significant finding for Turkish patients.

Anahtar Kelimeler:

Key words: BTNL2 gene, genetic predisposition, single nucleotide polymorphism, sarcoidosis

Is there a genetic predisposition for Turkish patients with sarcoidosis in the 329-bp region containing the BTNL2 rs2076530 polymorphism?

Keywords:

Key words: BTNL2 gene, genetic predisposition, single nucleotide polymorphism, sarcoidosis,

PDF

___

Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14: 735–737.
Uzkeser H, Karatay S, Yıldırım K, Eren S. Sarcoidosis and denim sandblasting: a case report. Turk J Med Sci 2013; 43: 343–345.
McGrath DS, Daniil Z, Foley P, du Bois JL, Lympany PA, Cullinan P, du Bois RM. Epidemiology of familial sarcoidosis in the UK. Thorax 2000; 55: 751–754.
Pietinalho A, Ohmichi M, Hirasawa M, Hiraga Y, Löfroos AB, Selroos O. Familial sarcoidosis in Finland and Hokkaido, Japan-a comparative study. Respir Med 1999; 93: 408–412.
Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J, Chase GA, Iannuzzi MC. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001; 153: 188–193.
Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc 2007; 4: 453–456.
Buck AA, McKusick VA. Epidemiologic investigations of sarcoidosis. III. Serum proteins, syphilis, association with tuberculosis: familial aggregation. Am J Hyg 1961; 74: 174–188.
Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC, ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 2005; 77: 491–499.
Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nature Genet 2005; 37: 357–364.
Stammers M, Rowen L, Rhodes D, Trowsdale J, Beck S. BTL-II: a polymorphic locus with homology to the butyrophilin gene family, located at the border of the major histocompatibility complex class II and class III regions in human and mouse. Immunogenetics 2000; 51: 373–382.
Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116–126.
Agostini C, Trentin L, Perin A, Facco M, Siviero M, Piazza F, Basso U, Adami F, Zambello R, Semenzato G. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol 1999; 277: L240–250.
Nguyen T, Liu XK, Zhang Y, Dong C. BTNL2, a butyrophilinlike molecule that functions to inhibit T cell activation. J Immunol 2006; 176: 7354–7360.
Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, Wells AU, Tzouvelekis A, van Moorsel CH, van den Bosch JM et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 2007; 70: 219–227.
Spagnolo P, Renzoni EA, Wells AU, Sato H, Grutters JC, Sestini P, Abdallah A, Gramiccioni E, Ruven HJ, du Bois RM et al. C-C chemokine receptor 2 and sarcoidosis: association with Löfgren’s syndrome. Am J Respir Crit Care Med 2003; 168: 1162–1166.
Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A, Vetter H, Grohé C. BTNL2 gene variant and sarcoidosis. Thorax 2006; 61: 273–274.
Milman N, Svendsen CB, Nielsen FC, van Overeem Hansen T. The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis. Clin Respir J 2011; 5: 105–111.
Morais A, Lima B, Peixoto MJ, Alves H, Marques A, Delgado L. BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis. Respir Med 2012; 106: 1771–7.
Adrianto I, Lin CP, Hale JJ, Levin AM, Datta I, Parker R, Adler A, Kelly JA, Kaufman KM, Lessard CJ et al. Genomewide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS One 2012; 7: e43907.
Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, Asukata Y, Takeuchi M, Ito N, Shibuya E et al. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest Ophthalmol Vis Sci 2012; 53: 7109–7115.